Genome-Wide Analysis of Differentially Expressed Genes and Splicing Isoforms in Clear Cell Renal Cell Carcinoma

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Valletti, Alessio ^a   Gigante, Margherita ^b   Palumbo, Orazio ^c   Carella, Massimo ^c   Divella, Chiara ^d   Sbisà, Elisabetta ^e   Tullo, Apollonia ^e   Picardi, Ernesto ^a,d   D'Erchia, Anna Maria ^a,d   Battaglia, Michele ^d   Gesualdo, Loreto ^d   Pesole, Graziano ^a   Ranieri, Elena ^b  

^a CNR   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

^c CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^d UNIVERSITY OF BARI   (Italy)

^e INSTITUTE OF BIOMEDICAL TECHNOLOGIES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CAVEOLIN 2; DAB2 PROTEIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; LAMININ ALPHA4; MESSENGER RNA; PROTEIN P67; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 4A3; RNA; SECRETED FRIZZLED RELATED PROTEIN 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TCF 21; TUMOR MARKER; UNCLASSIFIED DRUG; GENETIC MARKER;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER PROGNOSIS; CANCER TISSUE; CAV2 GENE; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DAB2 GENE; DIAGNOSTIC VALUE; EXON; FEMALE; GENE; GENE CASSETTE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; KCNJ1 GENE; KIDNEY CARCINOMA; LAMA4 GENE; MALE; PREDICTION; PTP4A3 GENE; QUANTITATIVE ANALYSIS; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SFRP GENE; TCF21 GENE; TREATMENT RESPONSE; ALTERNATIVE RNA SPLICING; CONFOCAL MICROSCOPY; GENE EXPRESSION REGULATION; GENETIC MARKER; GENETICS; KIDNEY TUMOR; METABOLISM; MICROARRAY ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

ALTERNATIVE SPLICING; CARCINOMA, RENAL CELL; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; KIDNEY NEOPLASMS; MICROARRAY ANALYSIS; MICROSCOPY, CONFOCAL; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84886043439     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078452     Document Type: Article

References (45)

1. Eble JN, Sauter G, Epstein JI, Sesterhenn IA, (2004) Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs; Kleihues P, Sobin LH, eds. Lyon: IARC Press. pp. pp. 7-85.
2. Vasudev NS, Selby PJ, Banks RE, (2012) Renal cancer biomarkers: the promise of personalised care. BMC Med 10: 112. doi:10.1186/1741-7015-10-112. PubMed: 23016578.
3. Latif F, Tory K, Gnarra J, Yao M, Duh FM, et al. (1993) Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260: 1317-1320. doi:10.1126/science.8493574. PubMed: 8493574.
4. Allory Y, Culine S, de la Taille A, (2011) Kidney cancer pathology in the new context of targeted therapy. Pathobiology 78: 90-98. doi:10.1159/000315543. PubMed: 21677472.
5. Pinto Marín A, Redondo Sánchez A, Espinosa Arranz E, Zamora Auñón P, Castelo Fernández B, et al. (2012) mTOR pathway inhibition in renal cell carcinoma. Urol Oncol Semin Orig Investig 30: 356-361. doi:10.1016/j.urolonc.2009.11.008. PubMed: 20207176.
6. Network TCGAR (2013) Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499: 43-49.
7. Fisher R, Gore M, Larkin J, (2012) Current and future systemic treatments for renal cell carcinoma. Semin Cancer Biol, 23: 38-45. PubMed: 22705280.
8. Arsanious A, Bjarnason GA, Yousef GM, (2009) From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma. Mol Cancer 8: 20. doi:10.1158/1535-7163.TARG-09-C20. PubMed: 19291329.
9. Jones J, Otu H, Spentzos D, Kolia S, Inan M, et al. (2005) Gene signatures of progression and metastasis in renal cell cancer. Clin Cancer Res 11: 5730-5739. doi:10.1158/1078-0432.CCR-04-2225. PubMed: 16115910.
10. Zhao H, Ljungberg B, Grankvist K, Rasmuson T, Tibshirani R, et al. (2006) Gene expression profiling predicts survival in conventional renal cell carcinoma. PLOS Med 3: e13. doi:10.1371/journal.pmed.0030013. PubMed: 16318415.
11. Sanjmyatav J, Steiner T, Wunderlich H, Diegmann J, Gajda M, et al. (2011) A specific gene expression signature characterizes metastatic potential in clear cell renal cell carcinoma. J Urol 186: 289-294. doi:10.1016/j.juro.2011.03.033. PubMed: 21600596.
12. Bratslavsky G, Sanford T, Srinivasan R, Aprelikova O, Liu J, et al. (2011) Differential genetic expression in large versus small clear cell renal cell carcinoma: results from microarray analysis. J Cancer 2: 271-279. PubMed: 21611108.
13. Brannon AR, Haake SM, Hacker KE, Pruthi RS, Wallen EM, et al. (2012) Meta-analysis of clear cell renal cell carcinoma gene expression defines a variant subgroup and identifies gender influences on tumor biology. Eur Urol 61: 258-268. doi:10.1016/j.eururo.2011.10.007. PubMed: 22030119.
14. Yu G, Yao W, Wang J, Ma X, Xiao W, et al. (2012) LncRNAs expression signatures of renal clear cell carcinoma revealed by microarray. PLOS ONE 7: e42377. doi:10.1371/journal.pone.0042377. PubMed: 22879955.
15. Osanto S, Qin Y, Buermans HP, Berkers J, Lerut E, et al. (2012) Genome-wide microRNA expression analysis of clear cell renal cell carcinoma by next generation deep sequencing. PLOS ONE 7: e38298. doi:10.1371/journal.pone.0038298. PubMed: 22745662.
16. Zhao Q, Caballero OL, Davis ID, Jonasch E, Tamboli P, et al. (2013) Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas. Clin Cancer Res, 19: 2460-72. PubMed: 23444225.
17. Martelli PL, D'Antonio M, Bonizzoni P, Castrignanò T, D'Erchia AM, et al. (2011) ASPicDB: a database of annotated transcript and protein variants generated by alternative splicing. Nucleic Acids Res 39: D80-D85. doi:10.1093/nar/gkq1073. PubMed: 21051348.
18. Castrignanò T, D'Antonio M, Anselmo A, Carrabino D, D'Onorio De Meo A, et al. (2008) ASPicDB: a database resource for alternative splicing analysis. Bioinformatics 24: 1300-1304. doi:10.1093/bioinformatics/btn113. PubMed: 18388144.
19. Sobin LH, Gospodarowicz MK, Wittekind C, (2009) TNM Classification of Malignant Tumours. John Wiley & Sons.
20. Hong SK, Jeong CW, Park JH, Kim HS, Kwak C, et al. (2011) Application of simplified Fuhrman grading system in clear-cell renal cell carcinoma. BJU Int 107: 409-415. doi:10.1111/j.1464-410X.2010.09561.x. PubMed: 20804473.
21. Huang da W, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57. PubMed: 19131956.
22. Huang da W, Sherman BT, Lempicki RA, (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1-13. doi:10.1093/nar/gkp505. PubMed: 19033363.
23. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034. PubMed: 12184808.
24. Rozen S, Skaletsky H, (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132: 365-386. PubMed: 10547847.
25. Peirson SN, Butler JN, Foster RG, (2003) Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis. Nucleic Acids Res 31: e73. doi:10.1093/nar/gng073. PubMed: 12853650.
26. Zimmerman MW, Homanics GE, Lazo JS, (2013) Targeted deletion of the metastasis-associated phosphatase Ptp4a3 (PRL-3) suppresses murine colon cancer. PLOS ONE 8: e58300. doi:10.1371/journal.pone.0058300. PubMed: 23555575.
27. Elsheikh SE, Green AR, Rakha EA, Samaka RM, Ammar AA, et al. (2008) Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype. Br J Cancer 99: 327-334. doi:10.1038/sj.bjc.6604463. PubMed: 18612310.
28. Huang X, Ji G, Wu Y, Wan B, Yu L, (2008) LAMA4, highly expressed in human hepatocellular carcinoma from Chinese patients, is a novel marker of tumor invasion and metastasis. J Cancer Res Clin Oncol 134: 705-714. doi:10.1007/s00432-007-0342-6. PubMed: 18084776.
29. Lugassy C, Torres-Muñoz JE, Kleinman HK, Ghanem G, Vernon S, et al. (2009) Overexpression of malignancy-associated laminins and laminin receptors by angiotropic human melanoma cells in a chick chorioallantoic membrane model. J Cutan Pathol 36: 1237-1243. doi:10.1111/j.1600-0560.2009.01273.x. PubMed: 19469865.
30. Ares GR, Caceres PS, Ortiz PA, (2011) Molecular regulation of NKCC2 in the thick ascending limb. Am J Physiol Renal Physiol 301: F1143-F1159. doi:10.1152/ajprenal.00396.2011. PubMed: 21900458.
31. Kinoshita T, Nomoto S, Kodera Y, Koike M, Fujiwara M, et al. (2011) Decreased expression and aberrant hypermethylation of the SFRP genes in human gastric cancer. Hepatogastroenterology 58: 1051-1056. PubMed: 21830441.
32. Smith LT, Lin M, Brena RM, Lang JC, Schuller DE, et al. (2006) Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer. Proc Natl Acad Sci U S A 103: 982-987. doi:10.1073/pnas.0510171102. PubMed: 16415157.
33. Tong JH, Ng DC, Chau SL, So KK, Leung PP, et al. (2010) Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma. BMC Cancer 10: 253. doi:10.1186/1471-2407-10-253. PubMed: 20525238.
34. Maurer ME, Cooper JA, (2005) Endocytosis of megalin by visceral endoderm cells requires the Dab2 adaptor protein. J Cell Sci 118: 5345-5355. doi:10.1242/jcs.02650. PubMed: 16263760.
35. Bonizzoni P, Rizzi R, Pesole G, (2005) ASPIC: a novel method to predict the exon-intron structure of a gene that is optimally compatible to a set of transcript sequences. BMC Bioinformatics 6: 244. doi:10.1186/1471-2105-6-244. PubMed: 16207377.
36. Tang X, Woodward T, Amar S, (2010) A PTP4A3 peptide PIMAP39 modulates TNF-alpha levels and endotoxic shock. J Innate Immun 2: 43-55. doi:10.1159/000235685. PubMed: 20375622.
37. Chidlow JH Jr., Sessa WC, (2010) Caveolae, caveolins, and cavins: complex control of cellular signalling and inflammation. Cardiovasc Res 86: 219-225. doi:10.1093/cvr/cvq075. PubMed: 20202978.
38. Kenne E, Soehnlein O, Genové G, Rotzius P, Eriksson EE, et al. (2010) Immune cell recruitment to inflammatory loci is impaired in mice deficient in basement membrane protein laminin alpha4. J Leukoc Biol 88: 523-528. PubMed: 20483922.
39. Gumz ML, Zou H, Kreinest PA, Childs AC, Belmonte LS, et al. (2007) Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma. Clin Cancer Res 13: 4740-4749. doi:10.1158/1078-0432.CCR-07-0143. PubMed: 17699851.
40. Liu H, Brannon AR, Reddy AR, Alexe G, Seiler MW, et al. (2010) Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma. BMC. Syst Biol 4: 51.
41. Costa VL, Henrique R, Danielsen SA, Eknaes M, Patrício P, et al. (2011) TCF21 and PCDH17 methylation: An innovative panel of biomarkers for a simultaneous detection of urological cancers. Epigenetics 6: 1120-30. PubMed: 21847011.
42. Dubosq F, Ploussard G, Soliman H, Turpin E, Latil A, et al. (2011) Identification of a three-gene expression signature of early recurrence in non-muscle-invasive urothelial cell carcinoma of the bladder. Urol Oncol, 30: 833-40. PubMed: 21489836.
43. Gaidatzis D, Jacobeit K, Oakeley EJ, Stadler MB, (2009) Overestimation of alternative splicing caused by variable probe characteristics in exon arrays. Nucleic Acids Res 37: e107. doi:10.1093/nar/gkp508. PubMed: 19528075.
44. Cattaneo E, Laczko E, Buffoli F, Zorzi F, Bianco MA, et al. (2011) Preinvasive colorectal lesion transcriptomes correlate with endoscopic morphology (polypoid vs. nonpolypoid). EMBO. Mol Med 3: 334-347.
45. Abdueva D, Wing MR, Schaub B, Triche TJ, (2007) Experimental comparison and evaluation of the Affymetrix exon and U133Plus2 GeneChip arrays. PLOS ONE 2: e913. doi:10.1371/journal.pone.0000913. PubMed: 17878948.